Clinical Trial Update: Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain [Phase 2]

View source ↗

Summary

Open-label Phase 2 safety study of EN3270 in adults with moderate to severe chronic non-malignant pain; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• EN3270

Snippet

Sponsor: Durect | Conditions: Chronic, Non Malignant Pain | Phase 2 | Status: COMPLETED